Article ID Journal Published Year Pages File Type
5691813 European Journal of Obstetrics & Gynecology and Reproductive Biology 2016 5 Pages PDF
Abstract
Our data suggests that metabolic comorbidities and commonly used drugs are associated with the prognosis of patients with ovarian cancer. Additional trials are needed to confirm these observations and test therapeutic interventions.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Obstetrics, Gynecology and Women's Health
Preview
The effect of metabolic comorbidities and commonly used drugs on the prognosis of patients with ovarian cancer
Authors
, , , , ,